Similarly, the MAPK and Wnt pathways, which are also commonly dysregulated in endometrial cancer (55, 56) (Fig. 4 and SI Appendix, Fig. S1), can enhance PLD expression through their downstream effects on transcription factors and other regulatory proteins. This evidence concerns the gene GPLD1 and endometrial cancer.